Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. PATH has developed a global tracker to try and approximate medical oxygen needs in low- and middle-income countries during the Covid-19 pandemic as a way to draw attention to the issue.
    Published: May 2021
  2. A form of SARS-CoV-2 first identified in South Africa is spreading rapidly, with mutations that could stymie vaccination efforts around the world.
    Published: April 2021
  3. PATH’s Bruce Innis, MD, discusses this promising new vaccine—and PATH’s role in developing it—with renowned science journalist Carl Zimmer.
    Published: April 2021
  4. New formulas and off-grid approaches could help mRNA vaccines get to more places around the world. PATH’s vaccine vial monitors are highlighted, and Pat Lennon explains the importance of thermostable vaccines in extending reach and access.
    Published: March 2021

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release